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The 4th International Workshop for 
the Study of Itch* was held 9–11 
September 2007 in San Francisco, 
California. For the first time, the meet-
ing was sponsored in part by a grant 
from the National Institute of Arthritis 
and Musculoskeletal and Skin Diseases 
and the Office of Rare Diseases of the 
National Institutes of Health. Also for 
the first time, the meeting was held 
under the auspices of the International 
Forum for the Study of Itch (IFSI). 
Organized by Earl and Mirela Carstens, 
the meeting was attended by more 
than 130 scientists and physicians 
from throughout the world. The work-
shop covered a vast range of topics, 
including the neurophysiology of itch 
in humans and animals, molecular 
mechanisms of itch, neurogenic inflam-
mation, and pharmacology of anti-
pruritics. Clinical aspects were well 
covered, and there was a lively discus-
sion of itch definitions. Other topics 
included clinical research on the epide-
miology and pathophysiology of itch in 
systemic disease, neuropathic itch, new 
treatments, and psychosocial aspects of 
chronic itch. Highlights of the meeting 
are presented below.
Itch neurophysiology
Since the discovery 10 years ago of 
unmyelinated (C-fiber) afferents in 
humans that are selectively responsive 
to histamine but mechanically insensi-
tive, it has been debated whether these 
fibers are the only ones that transmit 
itch. Clinically, it is well known that 
potent oral antihistamines do not relieve 
most types of itch. Moreover, mechani-
cal stimuli can evoke itch, prompting a 
renewed and timely effort to discover 
new itch fibers. Collaborating neurosci-
entists from Yale, John Hopkins, and the 
University of Minnesota were able to 
demonstrate the existence of novel pop-
ulations of peripheral afferent fibers, as 
well as spinothalamic tract neurons in 
primates, that respond to cowhage, the 
“velvet” bean plant whose pods con-
tain spicules that were demonstrated 
to induce cutaneous itch more than 
50 years ago by Walter Shelly. Mathias 
Ringkamp (John Hopkins University, 
Baltimore, MD) presented data from 
human psychophysical studies demon-
strating that cowhage spicules induced 
itch without flare. Topical antihista-
mines did not inhibit this itch, but cap-
saicin, a C-fiber depleter, did. Glenn 
Giesler and colleagues at the University 
of Minnesota (Minneapolis) presented 
new data on a subpopulation of identi-
fied spinothalamic tract (STT) neurons 
in primates that were activated by cow-
hage over a time course matching that 
of itch in humans. These neurons also 
responded to noxious mechanical and 
thermal stimuli but did not respond to 
histamine. A different subpopulation of 
STT neurons was unresponsive to cow-
hage, but responded to histamine again 
over a time course matching that of itch 
sensation. Their data suggest the exis-
tence of separate populations of STT 
neurons that signal itch of different ori-
gins to several thalamic nuclei involved 
in encoding itch.
Gil Yosipovitch (Wake Forest 
University, Winston-Salem, NC) pre-
sented data from a study using a new 
brain imaging technique—arterial spin 
labeling—that appears better suited 
to evaluate itch than functional mag-
netic resonance imaging or positron 
emission tomography. Atopic eczema 
patients suffering from chronic itch 
exhibited significant differences from 
healthy control subjects in the distribu-
tion of brain areas that were active both 
under baseline conditions and during 
histamine-evoked itch.
Molecular mechanisms of itch and 
genetic models
Zhou Feng Chen (Washington 
University, St. Louis, MO) presented 
findings using a differential screening 
technique to identify gastrin-releasing 
peptide receptor (GRPR) as a candidate 
neurotransmitter in the superficial spi-
nal dorsal horn that is involved in itch 
transmission. GRPR is a G protein–cou-
pled receptor derived from the bombe-
sin family. Mutant mice lacking GRPR 
exhibited significantly less scratching 
behavior in response to three pruritic 
agents—histamine, protease activated 
receptor-2 (PAR-2) agonist, and chloro-
quine—in a manner that was reversed 
by GRPR antagonists. The mutant mice 
displayed normal nociceptive respons-
es to noxious thermal and mechanical 
stimuli or tissue inflammation.
Jeffrey Mogil (McGill University, 
Montreal, Canada) discussed the role 
of genetic factors in the variability of 
histamine- and choloroquine-evoked 
scratching among 11 different inbred 
mouse strains, which differed up to 
2.5-fold. Furthermore, he demonstrated 
that female mice exhibited significantly 
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more pruritogen-evoked scratching (by 
23%) compared with male mice. He 
also provided evidence for a negative 
correlation between itch and pain, such 
that mouse strains exhibiting greater 
sensitivity to noxious stimuli exhibited 
less scratching, and vice versa. These 
findings may lead to the future identifi-
cation of itch-related genes.
Makoto Tominaga (Okazaki Institute, 
Tokyo, Japan) presented an overview 
of the possible role of thermosensitive 
transient receptor potential (TRP) chan-
nels in itch. He also presented data 
demonstrating that skin keratinocytes 
express a variety of thermoTRP chan-
nels and may be involved in detecting 
temperature and pruritic stimuli along 
with sensory nerve fibers.
Neuromodulators and itch
Martin Steinhoff (University of Münster, 
Germany) presented an overview of the 
mediators of neurogenic inflammation 
and the cross-talk among mast cells, 
dendritic cells, and T cells involved in 
the itch response. Mediators such as 
endothelin-converting enzyme 1 and 
neutral endopeptidase control sub-
stance-P degradation and neurokinin-
A-mediated signaling of inflammation 
and itch. An important role for proteases 
and their respective PAR receptors was 
initially reported by Steinhoff 7 years 
ago and continues to be extensively 
investigated by his group. Interactions 
with interleukin-31, a cytokine recently 
found to be a pruritogen in atopic ecze-
ma, were mentioned as potential targets 
for future antipruritic medications.
Yashushi Kuraishi (Toyoma 
University, Japan) presented data that 
refuted the common notion that mos-
quito-bite itch is solely histamine-
mediated. He reported that the volt-
age-dependent calcium channel α2ð-1 
subunit is involved in itch signaling 
by afferent nerve fibers of mice with 
allergic itch induced by an extract of 
mosquito salivary gland. Gabapentin 
reduced scratching evoked by mos-
quito salivary gland extract, but not 
histamine, in a dose-dependent man-
ner. This calcium-channel subunit was 
extensively coexpressed with the cap-
saicin and heat receptor TRPV1 in sen-
sory neurons. A poster from the same 
group demonstrated that itch associ-
ated with hypersensitization to mos-
quito bites is mediated by a lipoxin A4 
(LXA), a 5-lipoxygenase metabolite. 
Furthermore, mice with hypersensitiv-
ity to mosquito bites had elevated CD4 
T cells with receptors to LXA. These 
CD4 cells induced LXA4 itch in mice.
Treatments for itch
Several new antipruritic treatment 
modalities were presented at the meet-
ing. One of the new concepts is that 
an imbalance in central µ- and κ-opi-
oids may play a role in chronic itch. 
Support for this concept was presented 
by Hiroshi Umeuchi (Toray Industries, 
Urayasu, Japan) in a study of 59 patients 
with primary biliary cirrhosis (PBC), a 
cholestatic liver disease that is associ-
ated with severe itch. Patients experi-
encing itch exhibited higher plasma 
concentration of µ-opioids compared 
with patients not experiencing itch. 
In a mouse model of PBC, nalfurafine 
hydrochloride, a κ-agonist, signifi-
cantly inhibited scratching behavior. 
Kenji Takamori (Juntendo University, 
Urayasu, Japan) reported the results of 
a large double-blind study using nal-
furafine in 337 hemodialysis patients 
with pruritus resistant to other treat-
ments. The results demonstrated signifi-
cant reduction in itch intensity with a 
rather safe profile.
Sonja Ständer (University of Münster, 
Germany) presented results of a large, 
open-label study of 72 patients with 
chronic itch of different origins. The 
selective serotonin reuptake inhibitors 
paroxetine and fluvoxamine signifi-
cantly reduced itch in more than 50% 
of patients.
A major highlight of the workshop 
was the Handwerker Prize, awarded 
to a junior scientist whose poster was 
voted best by an impartial commit-
tee. The prize is named in honor of 
Hermann Handwerker (University of 
Erlangen, Germany), a pioneer in the 
field of itch research who has trained 
many neuroscientists in the field. The 
award was given to Steve Davidson 
(University of Minnesota, Minneapolis), 
who showed that scratching reduced 
the histamine- and cowhage-evoked 
responses of primate STT neurons in a 
manner consistent with the ability of 
scratching to relieve itch.
The 5th International Workshop for 
the Study of Itch is scheduled to take 
place in Kyoto, Japan, 25–28 October 
2009, and will be organized by Kenji 
Takamori of Juntendo University, 
Urayasu, Japan. For more information 
about future meetings, visit the IFSI 
online at http://www.itchforum.org.
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